News
ISET: Pythagoras study data on Aorfix™
Click for more details
Change of Nominated Adviser and Broker
Change of Nominated Adviser and Broker. To read more, click here.
Appointment of New CFO
Appointment of New CFO. To read more, click here.
VEITH Symposium 2011: Aorfix™
Aorfix™ provides clinicians with greater choice and flexibility.
Directorate Change
Directorate Change.
08 Sep 2011
LMT: Share Option Cancellation and Grant
30 Aug 2011
LMT: Share Option Grant
LMT: Interim Results for the six months ended 30 June 2011
08 Aug 2011
Regulatory Update - Final FDA Clinical Module Submission
Regulatory Update
29/06/2011
Total Voting Rights
31/05/2011
Directors's Interests
Directorate changes
26/05/2011
AGM Results
25/05/2011
Result of Offer
17/05/2011
Notice of AGM, Annual Report and Accounts
06/05/2011
Result of General Meeting
2010 Annual Report now available for download
2010 Annual Report - available here
20/04/2011
Issue of equity to raise up to £27.5 million to fund U.S. approval and launch of Aorfix™
Preliminary Results for the Year ended 31 December 2010
Winner of Aorfix™ Tortuosity Challenge is announced
Lombard Medical is delighted to confirm that Dr Sharmini Designa of Northwick Park Hospital in the UK is the winner...
21/03/2011
Aorfix™ Achieves 85% Market Share Growth in the UK
25/01/2011 Clinica
Lombard pumps life into endovascular stent graft market
15/12/2010 06:52 AM
Lombard Medical announces appointment of Dr. Peter Phillips to Board of Directors
15/12/2010 06:59 AM
Lombard Medical Technologies announces new management structure
13/12/2010 07:00 AM
Lombard Medical Submits Fifth PMA Module to FDA
25/11/2010 10:45:00 AM
22/11/2010 2:12:00 PM
CIRSE 2010: Aorfix™ Satellite Symposium Webcast
6/10/2010 11:12:00 AM
